第四届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300620 证券简称：光库科技 公告编号：2025-032 珠海光库科技股份有限公司 1、第四届董事会第十四次会议决议。 特此公告。 珠海光库科技股份有限公司 一、会议召开情况 珠海光库科技股份有限公司（以下简称"公司"）于2025年4月30日以现场 结合通讯方式在公司会议室召开了第四届董事会第十四次会议。会议通知及会议 资料于2025年4月28日以电子邮件或者直接送达方式送达全体董事。本次会议由 董事长郭瑾主持，应到董事9人，实到董事9人。本次会议的召开和表决程序符合 《中华人民共和国公司法》等法律、法规以及《珠海光库科技股份有限公司章程》 的规定，合法有效。 根据《上市公司监管指引第10号——市值管理》《深圳证券交易所创业板股 票上市规则》等有关法律、法规和规范性文件，为进一步加强公司市值管理工作， 规范公司市值管理行为，维护公司、投资者及其他利益相关者的合法权益，结合 公司实际情况，制定本制度。 具体内容详见公司刊载于巨潮资讯网（www.cninfo.com.c ...

珠海光库科技股份有限公司 市值管理制度 公司应当牢固树立回报股东意识，采取措施保护投资者尤其是中小投资者利益，诚实守 信、规范运作、专注主业、稳健经营，以新质生产力的培育和运用推动经营水平和发展质量 提升，并在此基础上做好投资者关系管理，增强信息披露质量和透明度，必要时积极采取措 施提振投资者信心，推动公司投资价值合理反映公司质量。 公司质量是公司投资价值的基础和市值管理的重要抓手，公司应当立足于提升公司质量， 依法依规运用各类方式提升公司投资价值。 第一章 总则 第一条 为加强珠海光库科技股份有限公司（下称"公司"）市值管理工作，规范公司 市值管理行为，维护公司、投资者及其他利益相关者的合法权益，根据《中华人民共和国公 司法》《中华人民共和国证券法》《上市公司监管指引第 10 号——市值管理》《深圳证券 交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》及其他有关法律法规，制订本制度。 第二条 市值管理，是指上市公司以提高上市公司质量为基础，为提升公司投资价值和 股东回报能力而实施的战略管理行为。 第五条 市值管理工作由董事会领导、经营管理层参与，董事会秘 ...

证券代码：300620 证券简称：光库科技 公告编号：2025-031 珠海光库科技股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 珠海光库科技股份有限公司（以下简称"公司"）2024年年度权益分派方案已获2025 年4月22日召开的2024年度股东大会审议通过，现将权益分派事宜公告如下： 一、股东大会审议通过权益分派方案的情况 1、2024年度股东大会审议通过了《关于2024年度利润分配预案的议案》，具体方 案为：以公司现有总股本249,180,545股为基数，向全体股东每10股派发现金股利人民币 1元（含税），合计派发现金股利人民币24,918,054.50元（含税），剩余未分配利润结转 至以后年度。本次不送红股，不以公积金转增股本。在本董事会决议公告之日起至实施 权益分派股权登记日期间，若公司总股本发生变动的，公司拟维持现金红利分配比例不 变，相应调整分配总额。 2、本次权益分派方案披露至实施期间，公司总股本未发生变化。 3、本次实施的权益分派方案与股东大会审议通过的权益分派方案一致。 4、本次实施权益分派 ...

光库科技（300620）公告，2025年第一季度营收为2.65亿元，同比增长65.53%；净利润为1084.48万 元，同比增长66.97%。 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥265,221,230.78, representing a 65.53% increase compared to ¥160,224,261.89 in the same period last year[5] - Net profit attributable to shareholders was ¥10,844,779.88, up 66.97% from ¥6,494,860.44 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥5,416,656.89, reflecting an 83.29% increase from ¥2,955,162.23 in the previous year[5] - Total operating revenue for the current period reached ¥265,221,230.78, a significant increase from ¥160,224,261.89 in the previous period, representing a growth of approximately 65.6%[24] - Net profit for the current period was ¥9,031,509.71, up from ¥6,494,860.44 in the previous period, reflecting a growth of approximately 39.5%[25] - The company reported a comprehensive income total of ¥16,100,177.60 for the current period, compared to a loss of ¥4,318,823.24 in the previous period[26] - Basic earnings per share for the current period were ¥0.0435, up from ¥0.0260 in the previous period, indicating an increase of approximately 67.3%[26] Assets and Liabilities - The company's total assets increased by 6.44% to ¥3,141,890,210.51 from ¥2,951,694,333.97 at the end of the previous year[5] - Total liabilities rose to ¥1,152,853,632.45, compared to ¥990,073,709.88 in the previous period, an increase of approximately 16.4%[23] - The company's equity attributable to shareholders increased to ¥1,954,415,823.05 from ¥1,925,186,598.91, showing a growth of about 1.5%[23] - The company's long-term borrowings increased by 52.97% to ¥248,284,843.36, primarily due to new long-term bank loans[10] - The long-term borrowings increased to ¥248,284,843.36 from ¥162,313,290.72, representing a growth of approximately 52.9%[23] Cash Flow - The net cash flow from operating activities was negative at -¥21,295,635.83, a decline of 118.55% compared to ¥114,788,343.70 in the same period last year[5] - Cash inflow from operating activities totaled 232,852,688.61 yuan, down from 257,700,656.72 yuan in the previous period, reflecting a decrease of approximately 9.7%[27] - Cash outflow from operating activities increased to 254,148,324.44 yuan, compared to 142,912,313.02 yuan in the previous period, representing an increase of about 77.5%[28] - Investment cash inflow rose sharply to 130,896,810.95 yuan from 11,111,135.93 yuan, marking an increase of approximately 1,078.5%[28] - Net cash flow from investment activities was negative at -40,801,911.46 yuan, an improvement from -111,311,910.08 yuan in the previous period[28] - Cash inflow from financing activities was 243,845,005.20 yuan, down from 291,466,352.76 yuan, a decrease of about 16.3%[28] - Net cash flow from financing activities was positive at 153,369,506.77 yuan, compared to 288,344,710.51 yuan in the previous period, indicating a decrease of approximately 46.8%[28] - The ending cash and cash equivalents balance increased to 509,649,710.28 yuan from 448,905,553.38 yuan, reflecting a growth of about 13.5%[28] - The company received 239,900,000.00 yuan in borrowings, significantly higher than 113,700,000.00 yuan in the previous period, indicating a strong reliance on debt financing[28] Research and Development - The company raised a net amount of RMB 697,054,124.51 for the lithium niobate high-speed modulator chip R&D project, with the project deadline extended to November 30, 2026[17] - The company is actively advancing the R&D of lithium niobate high-speed modulator chips and has initiated small batch production and shipment of some new products[17] - Research and development expenses for the current period were ¥38,034,885.11, compared to ¥31,477,996.82 in the previous period, reflecting an increase of approximately 20.8%[25] Market Presence and Shareholder Information - The company expanded its market presence, contributing to a 65.53% increase in revenue, driven by new customer development and the consolidation of Bai'an Industrial[10] - The total number of common shareholders at the end of the reporting period is 37,404[13] - The largest shareholder, Zhuhai Huafa Technology Industry Group Co., Ltd., holds 23.47% of shares, totaling 58,482,396 shares[13] Operational Developments - The company raised a net amount of RMB 175,314,155.53 for the Guangku Thailand LLC production base project, with the project deadline extended to March 31, 2026[19] - The company has completed the construction of the factory for the Thailand Guangku production base and is in the process of customer sample delivery and confirmation[19] Audit and Reliability - The company did not undergo an audit for the first quarter report, which may affect the reliability of the financial data presented[29]

2、本次股东大会不涉及变更以往股东大会已通过决议的情况。 一、会议召开和出席情况 1、会议召开时间 证券代码：300620 证券简称：光库科技 公告编号：2025-029 珠海光库科技股份有限公司 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情形； （1）现场会议召开时间：2025 年 4 月 22 日（星期二）下午 14:30 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025 年 4 月 22 日 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易所互联 网系统投票的具体时间为：2025 年 4 月 22 日 9:15-15:00 期间的任意时间。 2、现场会议召开地点：广东珠海市高新区唐家湾镇创新三路 399 号 7 楼会议 室。 3、会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式召开。 4、会议召集人：公司董事会 5、会议主持人：董事长郭瑾女士 6、本次会议的召集和召开符合《中华人民共和国证券法》 ...

北京德恒（深圳）律师事务所 关于珠海光库科技股份有限公司 2024 年度股东大会的 法律意见 深圳市福田区金田路 4018 号安联大厦 B 座 11 楼 电话:0755-88286488 传真:0755-88286499 邮编:518026 北京德恒（深圳）律师事务所 关于珠海光库科技股份有限公司 2024年度股东大会的法律意见 北京德恒（深圳）律师事务所 关于珠海光库科技股份有限公司 2024 年度股东大会的 法律意见 德恒 06G20240208-00002 号 致：珠海光库科技股份有限公司 珠海光库科技股份有限公司（以下简称"公司"）2024 年度股东大会（以下 简称"本次会议"）于 2025 年 4 月 22 日（星期二）召开。北京德恒（深圳）律 师事务所（以下简称"德恒"）受公司委托，指派唐永生律师、郑珠玲律师（以 下简称"德恒律师"）列席了本次会议。根据《中华人民共和国证券法》（以下 简称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、 中国证券监督管理委员会《上市公司股东会规则》（以下简称"《股东会规则》"）、 《珠海光库科技股份有限公司章程》（以下简称"《公司章程》"）的 ...

珠海光库科技股份有限公司 投资者关系活动记录表 编号：2025001 | 投资者关 | □特定对象调研 | □分析师会议 | □媒体采访 | 业绩说明会 | | --- | --- | --- | --- | --- | | 系活动类 | □新闻发布会 | □路演活动 | □现场参观 | | | 别 | □其他 | | | | | 参与单位 | | | | | | 及人员姓 | 线上参与公司2024年年度报告网上说明会的投资者 | | | | | 名 | | | | | | 时间 | 2025年4月18日下午15:00-16:00 | | | | | 地点 | 同花顺路演平台 | | | | | 上市公司 | 联席董事长、总经理Wang Xinglong先生；副总经理吉贵军先生；独立董事刘 | | | | | 接待人员 | 成昆先生；副总经理、董事会秘书吴炜先生；财务总监姚韵莉女士；保荐代表 | | | | | 姓名 | 人胡彦威先生。 | | | | | | 公司与本次参与业绩说明会的投资者进行了网上互动交流，就投资者关注的 | | | | | | 问题进行了回复。具体问题回复如下： | | | | | ...

Industry Overview - The Chinese optical communication industry is experiencing historic development opportunities driven by artificial intelligence, computing power networks, and the digital economy [1] - The market size of China's optical communication is expected to exceed 175 billion yuan by 2025, with a compound annual growth rate of 12%, accounting for over 50% of the global market share [1] Company Performance - Zhongji Xuchuang is projected to achieve a revenue of 23.861 billion yuan in 2024, a year-on-year increase of 122.63%, and a net profit of 5.171 billion yuan, up 137.9% [1] - Tianfu Communication is expected to realize a net profit of 1.256 billion to 1.401 billion yuan in 2024, representing a growth of 72% to 92% [1] - Xinyi Sheng is forecasted to achieve a net profit of 2.830 billion yuan in 2024, a significant increase of 311% [1] - Guangku Technology anticipates a net profit of 66.983 million yuan in 2024, reflecting a year-on-year growth of 12.32% [2] Technological Advancements - The optical communication industry has entered a technology iteration cycle centered on computing power demand, with 800G/1.6T optical modules and CPO technology expected to reshape the competitive landscape [2] - CPO (Co-Packaged Optics) and OIO (Optical Interconnect) technologies are projected to open new market opportunities, with the CPO market potentially reaching 19.2 billion USD and the OIO market potentially reaching 69.1 billion USD under neutral assumptions [2]

Group 1 - Company Instech reported a net profit of 177 million yuan for 2024, a year-on-year increase of 28.15%, with a proposed cash dividend of 1.20 yuan per 10 shares [1] - Instech achieved an operating revenue of 1.185 billion yuan in 2024, representing a year-on-year growth of 24.45% [1] - The company specializes in the research, production, and sales of rare earth permanent magnet materials and applications [2] Group 2 - Company Junda reported a net loss of 106 million yuan for Q1 2025, transitioning from profit to loss, with a year-on-year revenue decline of 49.52% [3] - Junda's operating revenue for Q1 2025 was 1.875 billion yuan [3] - The company focuses on the research, production, and sales of photovoltaic cell products [4] Group 3 - Company Annada reported a net loss of 10.26 million yuan for Q1 2025, with a year-on-year revenue increase of 1.44% [5] - Annada's operating revenue for Q1 2025 was 473 million yuan [5] - The company specializes in titanium dioxide and iron phosphate products [6] Group 4 - Company Jiuzhou Pharmaceutical reported a net profit of 250 million yuan for Q1 2025, a year-on-year increase of 5.68% [7] - Jiuzhou's operating revenue for Q1 2025 was 1.49 billion yuan, reflecting a year-on-year growth of 0.98% [7] - The company provides custom research and production services for pharmaceutical companies and research institutions [8] Group 5 - Company Yitong Century won a 1.48 billion yuan contract for a 5G comprehensive maintenance project with Guangdong Unicom [9] - The project will enhance the company's business volume and expansion in Guangdong [9] - Yitong Century specializes in communication network technology services and solutions [10] Group 6 - Company Rijiu Optoelectronics reported a net profit of 67.47 million yuan for 2024, a year-on-year increase of 506.9%, with a proposed cash dividend of 2.00 yuan per 10 shares [10] - Rijiu's operating revenue for 2024 was 583 million yuan, representing a year-on-year growth of 22% [10] - The company focuses on the research, production, and sales of touch display application materials [11] Group 7 - Company Ruotong reported a net profit of 95.98 million yuan for 2024, a year-on-year increase of 0.91%, with a proposed cash dividend of 2.00 yuan per 10 shares [12] - Ruotong's operating revenue for 2024 was 408 million yuan, reflecting a year-on-year growth of 7.54% [12] - The company specializes in drilling and completion equipment for oil and gas [13] Group 8 - Company Shuangxiang reported a net profit of 472 million yuan for 2024, a year-on-year increase of 754.84%, with a proposed cash dividend of 1.50 yuan per 10 shares [14] - Shuangxiang's operating revenue for 2024 was 2.29 billion yuan, representing a year-on-year growth of 51.55% [14] - The company focuses on synthetic leather and optical-grade PMMA products [15] Group 9 - Company Xinfang Pharmaceutical reported a net profit of 101 million yuan for 2024, a year-on-year decrease of 64.70%, with a proposed cash dividend of 0.30 yuan per 10 shares [16] - Xinfang's operating revenue for 2024 was 6.032 billion yuan, reflecting a year-on-year decline of 6.63% [16] - The company is involved in medical services, pharmaceutical distribution, and manufacturing [17] Group 10 - Company Dongxing Medical reported a net profit of 97.42 million yuan for 2024, a year-on-year increase of 0.21%, with a proposed cash dividend of 6.00 yuan per 10 shares [18] - Dongxing's operating revenue for 2024 was 435 million yuan, reflecting a year-on-year growth of 0.40% [18] - The company specializes in surgical medical devices [19] Group 11 - Company Wuzhou Special Paper reported a net profit of 64.68 million yuan for Q1 2025, a year-on-year decrease of 51.56%, with an operating revenue of 1.989 billion yuan [20] - Wuzhou's operating revenue for Q1 2025 increased by 15.21% [20] - The company focuses on the research, production, and sales of mechanism paper and pulp [21] Group 12 - Company Jinrui Mining expects a net profit of 15.28 million yuan for Q1 2025, a year-on-year increase of 617.40% [22] - The company specializes in the production and sales of strontium salt products [23] Group 13 - Company Youyan New Materials expects a net profit of 60 million to 75 million yuan for Q1 2025, a year-on-year increase of 13076% to 16370% [24] - The company focuses on electronic films, precious metal materials, and rare earth materials [25] Group 14 - Company Guoli expects a net profit of 11 million to 13 million yuan for Q1 2025, a year-on-year increase of 164.38% to 212.45% [26] - The company specializes in urban infrastructure design, construction, and investment [27] Group 15 - Company Shenzhen Airport reported a passenger throughput of 5.5422 million in March, a year-on-year increase of 8.70% [28] - The airport's cargo throughput was 171,900 tons, reflecting a year-on-year growth of 14.51% [28] - The company is involved in aviation and related non-aviation businesses [29] Group 16 - Company Shenghui Integration reported an order balance of 2.117 billion yuan as of March 31, 2025, a year-on-year increase of 11.89% [30] - The company provides cleanroom engineering and electromechanical engineering services [31] Group 17 - Company Chengyi Pharmaceutical received a drug registration certificate for Mercaptopurine tablets [32] - The drug is applicable for various diseases including choriocarcinoma and acute lymphoblastic leukemia [32] Group 18 - Company Enhua Pharmaceutical initiated Phase I clinical trials for NH280105 capsules, targeting Alzheimer's disease [33] - The trial aims to assess the safety and pharmacokinetics of the drug [33] Group 19 - Company Lingang Steel proposed a share buyback of 50 million to 100 million yuan [34] - The company specializes in the production and development of metallurgical products [35] Group 20 - Company Fujia plans to repurchase shares worth 15 million to 30 million yuan [36] - The company focuses on smart cleaning appliances and key components [37] Group 21 - Company Mould Technology received a project designation letter for exterior parts from a luxury car client, with an estimated total sales of 2.07 billion yuan [38] - The project is expected to start mass production in April 2027 [38] Group 22 - Company Longxin General expects a net profit of 4.55 billion to 5.30 billion yuan for Q1 2025, a year-on-year increase of 76.65% to 105.77% [39] - The company specializes in motorcycles, engines, and general machinery products [40] Group 23 - Company Dongfang Securities reported a net profit of 1.436 billion yuan for Q1 2025, a year-on-year increase of 62.08% [41] - The company focuses on investment management and securities trading [42] Group 24 - Company Yalian Machinery plans to use up to 800 million yuan of idle funds for low-risk financial products [43] - The company specializes in the production of engineered wood production lines and equipment [44] Group 25 - Company Guanghua Technology reported a net loss of 205 million yuan for 2024, with total revenue of 2.589 billion yuan [45] - The company focuses on PCB chemicals and lithium battery materials [46] Group 26 - Company Boya Biotechnology plans to publicly transfer 80% of its subsidiary's equity for 213 million yuan [47] - The transaction aims to optimize resource allocation focusing on blood products [48] Group 27 - Company Darui Electronics plans to repurchase shares worth 30 million to 50 million yuan [49] - The company specializes in customized components and automation equipment [50] Group 28 - Company Hongying Intelligent plans to repurchase shares worth 30 million to 40 million yuan [51] - The company focuses on smart control products and assemblies [52] Group 29 - Company Guangku Technology announced a change in the upper shareholding structure of its controlling shareholder [53] - The operational activities of the company will not be materially affected [54] Group 30 - Company Dingjie Smart's application for convertible bond issuance has been accepted by the Shenzhen Stock Exchange [55] - The company provides digital and intelligent solutions for various industries [56]